Renovis Surgical received FDA 510(k) clearance to market the Tesera™ SC porous titanium cervical interbody fusion system.
The standalone system, like all Tesera implants, is fabricated via additive manufacturing (3D printing) to create a highly-porous surface structure.
Source: Renovis Surgical Technologies, Inc.
This is the fourth product group featuring Tesera porous titanium for which Renovis has received FDA clearance, following:
- Tesera SA for standalone anterior spinal fusion (cleared 3Q13)
- Tesera Acetabular for adult reconstruction (cleared 2Q14)
- Tesera Posterior Lumbar Interbody (cleared 1Q15)
Renovis Surgical received FDA 510(k) clearance to market the Tesera™ SC porous titanium cervical interbody fusion system.
The standalone system, like all Tesera implants, is fabricated via additive manufacturing (3D printing) to create a highly-porous surface structure.
Source: Renovis Surgical Technologies, Inc.
This is the fourth...
Renovis Surgical received FDA 510(k) clearance to market the Tesera™ SC porous titanium cervical interbody fusion system.
The standalone system, like all Tesera implants, is fabricated via additive manufacturing (3D printing) to create a highly-porous surface structure.
Source: Renovis Surgical Technologies, Inc.
This is the fourth product group featuring Tesera porous titanium for which Renovis has received FDA clearance, following:
- Tesera SA for standalone anterior spinal fusion (cleared 3Q13)
- Tesera Acetabular for adult reconstruction (cleared 2Q14)
- Tesera Posterior Lumbar Interbody (cleared 1Q15)
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
